Outcomes of Ribavirin Free Treatment of Recurrent Genotype 1, Hepatitis C Infection Post Liver Transplant.

被引：0
|
作者：
Jones, D. [1 ]
Baggett, S. [1 ]
Shoreibah, M. [2 ]
Massoud, O. [2 ]
机构：
[1] UAB Hosp, Dept Pharm, Birmingham, AL USA
[2] UAB Hosp, Dept Gastroenterol, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D285
引用
收藏
页码：790 / 790
页数：1
相关论文
共 50 条
  • [1] Outcomes of ribavirin free regimens for treatment of recurrent hepatitis C (genotype1) infection post liver transplant
    Shoreibah, Mohamed G.
    Jones, DeAnn
    Baggett, Sarah
    McGuire, Brendan M.
    Massoud, Omar
    [J]. HEPATOLOGY, 2015, 62 : 790A - 790A
  • [2] Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant.
    Gutierrez, K.
    Scheuermann, J.
    Goldvarg, I.
    Joshi, S.
    Tyson, G.
    Bzowej, N.
    Girgrah, N.
    Anders, S.
    Loss, G.
    Therapondos, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 793 - 794
  • [3] Sofosbuvir/Ledipasvir without Ribavirin is effective in the treatment of recurrent hepatitis C infection post liver transplant
    Shoreibah, Mohamed G.
    Jones, Deann
    Orr, Jordan
    Zhang, Jie
    Venkata, Krishna V.
    Massoud, Omar I.
    [J]. HEPATOLOGY, 2016, 64 : 995A - 996A
  • [4] Interferon alfa and ribavirin in established post liver transplant recurrent hepatitis C infection
    Kapur, A
    Rodriguez, MJ
    Schecter, S
    Tzakis, AG
    Schiff, ER
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A1268 - A1268
  • [5] Ribavirin levels in post liver transplant patients treated for recurrent hepatitis C viral infection
    Jain, A
    Vekatramanan, R
    Yelochan, B
    Kashyap, R
    Marcos, A
    Fung, J
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (07) : 3190 - 3196
  • [6] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Mohamed Shoreibah
    Jordan Orr
    DeAnn Jones
    Jie Zhang
    Krishna Venkata
    Omar Massoud
    [J]. Hepatology International, 2017, 11 : 434 - 439
  • [7] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Shoreibah, Mohamed
    Orr, Jordan
    Jones, DeAnn
    Zhang, Jie
    Venkata, Krishna
    Massoud, Omar
    [J]. HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 434 - 439
  • [8] Hepatitis C Genotype Influences Post-liver Transplant Outcomes
    Campos-Varela, Isabel
    Lai, Jennifer C.
    Verna, Elizabeth C.
    O'Leary, Jacqueline G.
    Stravitz, R. Todd
    Forman, Lisa M.
    Trotter, James F.
    Brown, Robert S.
    Terrault, Norah A.
    [J]. TRANSPLANTATION, 2015, 99 (04) : 835 - 840
  • [9] A Modified Ribavirin- free Interferon Therapy With Boceprevir in Post- Liver Transplant Recurrent Hepatitis C
    Maticic, Mojca
    Luznik, Zala
    Stepec, Srecko
    Popovic, Peter
    Snedec, Nejc
    Poljak, Mario
    Stanisavljevic, Dragan
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2014, 48 (05) : 464 - 465
  • [10] Mechanism of action of ribavirin in treatment of recurrent hepatitis C after liver transplant
    Ouadri, R
    Giostra, E
    Rubbia-Brandt, L
    Mentha, G
    Malè, PJ
    Hadengue, A
    Negro, F
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 91 - 91
12345